Diabetic foot ulcer

Background

  • A diabetic foot ulcer (DFU) is a break in the skin of the foot in a person with diabetes that fails to heal promptly.
  • DFUs occur in approximately 15–25% of diabetic patients over their lifetime and are the leading cause of non-traumatic lower extremity amputation.[1] The ED physician's role is to assess ulcer severity, identify infection and limb-threatening complications, initiate appropriate treatment, and determine disposition.
  • Diabetic foot ulcers result from the convergence of three pathologic processes:
    • Peripheral neuropathy (~60% of cases) — loss of protective sensation leads to repetitive unrecognized trauma
    • Peripheral arterial disease (~15–20%) — impaired perfusion compromises healing and host defense
    • Immunopathy — hyperglycemia impairs neutrophil function, increasing infection risk
  • A foot ulcer that becomes infected (diabetic foot infection) is a limb-threatening emergency
  • 1-year outcomes of patients presenting with an infected DFU: ~46% healed, ~15% dead, ~17% required amputation[2]
  • 5-year mortality after major amputation exceeds 50%

Clinical Features

Ulcer characteristics

  • Typically on pressure points: plantar metatarsal heads, tips of toes, heel, dorsal interphalangeal joints
  • Neuropathic ulcers: Painless, well-circumscribed, surrounded by callus, located on plantar surface
  • Ischemic ulcers: Painful, irregular borders, pale or necrotic base, located on tips of toes or lateral foot
  • Neuroischemic (mixed): Features of both; most common in practice

Signs of infection (IDSA/IWGDF classification)

  • Uninfected: Ulcer present without signs of infection
  • Mild (local) infection: ≥2 of the following: erythema >0.5 cm but ≤2 cm around wound, local warmth, tenderness/pain, swelling, purulent discharge — confined to skin and superficial subcutaneous tissue
  • Moderate infection: Local infection with erythema >2 cm, or involvement of structures deeper than skin/subcutaneous tissue (abscess, osteomyelitis, septic arthritis, tendon involvement) — without systemic inflammatory response
  • Severe infection: Local infection with SIRS criteria (temperature >38°C or <36°C, HR >90, RR >20, WBC >12,000 or <4,000) — this is limb- and life-threatening[1]

Red flags in the ED

Differential Diagnosis

Foot infection

Skin and Soft Tissue

Deep Tissue / Limb-Threatening

Bone and Joint

Look A-Likes


Skin and Soft Tissue Infection

Look-A-Likes

Evaluation

Workup

Assess the whole patient:

  • Vital signs (identify sepsis/SIRS)
  • Point-of-care glucose; basic metabolic panel (renal function, electrolytes, glucose, acidosis)
  • CBC with differential
  • ESR, CRP, procalcitonin (support but do not confirm infection diagnosis)
  • Blood cultures if febrile, septic, or moderate-severe infection
  • HbA1c if not recently available (indicates long-term glycemic control)

Assess the affected limb:

  • Vascular assessment: Palpate dorsalis pedis and posterior tibial pulses. Assess capillary refill. Document any pulse deficits. Ankle-brachial index (ABI) if available (>0.9 normal; <0.4 suggests critical limb ischemia; note: ABI may be falsely elevated >1.3 in calcified vessels common in diabetes)
  • Neurologic assessment: Test sensation with 10 g monofilament (or sharp end of a broken wooden cotton applicator if monofilament unavailable). Loss of sensation at ≥1 site indicates neuropathy[3]
  • Lymphatic assessment: Ascending lymphangitis or lymphadenopathy suggests spreading infection

Assess the wound:

  • Document location, size (length × width × depth), and wound bed characteristics (granulation vs. slough vs. necrotic tissue)
  • Probe to bone test: Using a sterile blunt metal probe, gently probe the wound base. If you can feel bone, the positive predictive value for osteomyelitis is ~89% in high-risk ulcers[1]
  • Identify undermining, tunneling, sinus tracts, or fluctuance (deep space abscess)
  • Note wound odor (foul odor suggests anaerobic involvement)

Cultures:

  • Do not culture clinically uninfected ulcers — recovered organisms represent colonization, not infection[1]
  • For infected ulcers: Obtain tissue culture (curette or biopsy of wound base after debridement) rather than superficial wound swab when possible. Deep tissue cultures are more reliable than swabs
  • If swab is the only option, cleanse wound first and sample the wound base (not surface exudate)

Imaging:

  • Plain radiographs of the foot — obtain on all moderate/severe infections and any ulcer where osteomyelitis is suspected. Look for: soft tissue gas, foreign bodies, bony destruction, periosteal reaction, cortical disruption
  • MRI — gold standard for osteomyelitis diagnosis if plain films are equivocal and clinical suspicion remains high
  • Ultrasound — useful at bedside to identify fluid collections/abscesses in the plantar space

Diagnosis

Wagner Classification

Grade Description
0 Intact skin; pre-ulcerative lesion, deformity, or cellulitis
1 Superficial ulcer (partial or full-thickness)
2 Deep ulcer extending to tendon, ligament, joint capsule, or bone — without abscess or osteomyelitis
3 Deep ulcer with abscess, osteomyelitis, or tendon involvement
4 Localized gangrene (forefoot or heel)
5 Extensive gangrene involving the entire foot
  • Wagner grades ≥3 generally require surgical consultation and likely admission[4]

Management

All diabetic foot ulcers

  • Glycemic control: Optimize glucose management; hyperglycemia impairs immune function and healing
  • Offloading: The most important factor for healing neuropathic ulcers — instruct patient on strict non-weight-bearing or provide offloading shoe/boot. Referral for total contact casting as outpatient
  • Wound care: Debridement of necrotic tissue and surrounding callus (can be performed in the ED for superficial ulcers). Moist wound dressing. Avoid soaking the foot

Uninfected ulcers

  • No antibiotics — antibiotics do not improve healing of uninfected DFUs and promote resistance[1]
  • Wound care, offloading, glucose optimization
  • Outpatient follow-up with wound care or podiatry within 1–2 weeks

Mild infection

  • Oral antibiotics targeting Gram-positive cocci (most common pathogens: S. aureus and beta-hemolytic streptococci)[1]
  • Non-MRSA risk: Cephalexin 500 mg PO QID or amoxicillin-clavulanate 875/125 mg PO BID
  • MRSA risk (prior MRSA, purulence, IVDU, recent hospitalization): TMP-SMX DS 1–2 tabs PO BID or doxycycline 100 mg PO BID (add cephalexin if need Strep coverage with TMP-SMX)
  • Duration: 1–2 weeks; re-evaluate if not improving
  • Outpatient management with close follow-up

Moderate infection

  • IV antibiotics; consider admission
  • Non-MRSA: Ampicillin-sulbactam 3 g IV q6h or piperacillin-tazobactam 3.375 g IV q6h or ertapenem 1 g IV daily
  • MRSA risk: Add vancomycin 15–20 mg/kg IV
  • Surgical consultation for abscess drainage, deep space infection, or suspected osteomyelitis requiring debridement
  • If probe-to-bone positive or imaging suggests osteomyelitis, treat as osteomyelitis (prolonged antibiotics ± surgery; consult ID and surgery)

Severe infection (limb- and life-threatening)

  • Resuscitate: IV fluids, correct hyperglycemia/DKA/electrolytes, vasopressors if needed
  • Broad-spectrum IV antibiotics: Vancomycin + piperacillin-tazobactam (or meropenem if Pseudomonas/resistant organisms suspected)
  • Emergent surgical consultation — urgent debridement, drainage, and assessment for necrotizing soft tissue infections or the need for amputation
  • Blood cultures, lactate
  • ICU admission if septic shock

Vascular assessment and referral

  • If absent pulses, ABI <0.5, or signs of critical limb ischemia (rest pain, tissue loss, gangrene), obtain urgent vascular surgery consultation — revascularization may be needed before the ulcer can heal

Disposition

  • Discharge with close outpatient follow-up (1–2 weeks): Uninfected ulcers; mild infections with reliable patient, adequate perfusion, and no systemic toxicity
  • Admit for: Moderate-severe infection, sepsis/SIRS, limb-threatening ischemia, need for IV antibiotics, surgical intervention, inability to perform wound care at home, unreliable follow-up, failed outpatient management, concurrent DKA/metabolic derangement
  • Surgical consultation before discharge if: Wagner ≥3, suspected osteomyelitis, deep space abscess, gangrene, crepitus, or necrotizing soft tissue infections
  • All patients: Counsel on offloading, glucose control, daily foot self-inspection, appropriate footwear, and warning signs to return (worsening redness, streaking, fever, foul odor, new drainage)

See Also

External Links

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 Lipsky BA, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132-e173.
  2. ↑ IWGDF/IDSA. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes. 2023.
  3. ↑ Phelps JT, Doty CI. The diabetic foot infection: when and what types of antibiotics are warranted. emDocs. January 2019.
  4. ↑ Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2(2):64-122.
Obtenido de «https://www.wikem.org/w/index.php?title=Diabetic_foot_ulcer&oldid=389270»